S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Wall Street adds more to its big January after strong week
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Wall Street adds more to its big January after strong week
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Wall Street adds more to its big January after strong week
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Wall Street adds more to its big January after strong week
NYSE:EHC

Encompass Health - EHC Stock Forecast, Price & News

$61.39
-0.42 (-0.68%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$60.48
$61.81
50-Day Range
$55.86
$62.68
52-Week Range
$44.33
$74.61
Volume
1.62 million shs
Average Volume
502,101 shs
Market Capitalization
$6.13 billion
P/E Ratio
22.57
Dividend Yield
0.97%
Price Target
$64.13

Encompass Health MarketRank™ Forecast

Analyst Rating
Buy
3.17 Rating Score
Upside/​Downside
4.5% Upside
$64.13 Price Target
Short Interest
Healthy
2.58% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.71
Upright™ Environmental Score
News Sentiment
0.88mentions of Encompass Health in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$100,046 Bought Last Quarter
Proj. Earnings Growth
15.77%
From $2.79 to $3.23 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.73 out of 5 stars

Medical Sector

67th out of 1,055 stocks

Hospitals Industry

2nd out of 3 stocks


EHC stock logo

About Encompass Health (NYSE:EHC) Stock

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984, and is headquartered in Birmingham, AL.

Receive EHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

EHC Stock News Headlines

Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Encompass Health's (EHC) Plan Marks Entry in Rhode Island
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Health care giant Encompass growing to meet needs
Is Encompass Health (EHC) a Smart Lon-Term Investment?
Preview: Encompass Health's Earnings
See More Headlines
Receive EHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

EHC Company Calendar

Last Earnings
10/27/2021
Ex-Dividend for 1/17 Dividend
12/30/2022
Dividend Payable
1/17/2023
Today
1/28/2023
Next Earnings (Confirmed)
2/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Hospitals
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
42192430
Employees
43,400
Year Founded
1984

Price Target and Rating

Average Stock Price Forecast
$64.13
High Stock Price Forecast
$72.00
Low Stock Price Forecast
$58.00
Forecasted Upside/Downside
+4.5%
Consensus Rating
Buy
Rating Score (0-4)
3.17
Research Coverage
6 Analysts

Profitability

Net Income
$412.20 million
Pretax Margin
10.32%

Debt

Sales & Book Value

Annual Sales
$5.12 billion
Cash Flow
$6.87 per share
Book Value
$23.69 per share

Miscellaneous

Free Float
97,094,000
Market Cap
$6.13 billion
Optionable
Optionable
Beta
1.03

Social Links


Key Executives

  • Mark J. Tarr
    President, Chief Executive Officer & Director
  • Douglas E. Coltharp
    Chief Financial Officer & Executive Vice President
  • Elissa Joy CharbonneauElissa Joy Charbonneau
    Chief Medical Officer
  • John Patrick Darby
    Secretary, Executive VP & General Counsel
  • Andrew L. PriceAndrew L. Price
    Chief Accounting Officer & Senior Vice President













EHC Stock - Frequently Asked Questions

Should I buy or sell Encompass Health stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" EHC shares.
View EHC analyst ratings
or view top-rated stocks.

What is Encompass Health's stock price forecast for 2023?

6 brokerages have issued 12-month target prices for Encompass Health's shares. Their EHC share price forecasts range from $58.00 to $72.00. On average, they predict the company's stock price to reach $64.13 in the next twelve months. This suggests a possible upside of 4.5% from the stock's current price.
View analysts price targets for EHC
or view top-rated stocks among Wall Street analysts.

How have EHC shares performed in 2023?

Encompass Health's stock was trading at $59.81 at the beginning of 2023. Since then, EHC shares have increased by 2.6% and is now trading at $61.39.
View the best growth stocks for 2023 here
.

Are investors shorting Encompass Health?

Encompass Health saw a drop in short interest in the month of December. As of December 30th, there was short interest totaling 2,520,000 shares, a drop of 8.4% from the December 15th total of 2,750,000 shares. Based on an average daily volume of 684,500 shares, the days-to-cover ratio is presently 3.7 days. Approximately 2.6% of the company's shares are sold short.
View Encompass Health's Short Interest
.

When is Encompass Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 7th 2023.
View our EHC earnings forecast
.

How can I listen to Encompass Health's earnings call?

Encompass Health will be holding an earnings conference call on Wednesday, February 8th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Encompass Health's earnings last quarter?

Encompass Health Co. (NYSE:EHC) released its quarterly earnings data on Wednesday, October, 27th. The company reported $1.03 earnings per share for the quarter, missing analysts' consensus estimates of $1.06 by $0.03. The firm earned $1.28 billion during the quarter, compared to the consensus estimate of $1.31 billion. Encompass Health had a net margin of 5.39% and a trailing twelve-month return on equity of 15.59%. The company's revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.78 EPS.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health declared a quarterly dividend on Wednesday, October 19th. Stockholders of record on Tuesday, January 3rd will be paid a dividend of $0.15 per share on Tuesday, January 17th. This represents a $0.60 annualized dividend and a dividend yield of 0.98%. The ex-dividend date is Friday, December 30th.
Read our dividend analysis for EHC
.

Is Encompass Health a good dividend stock?

Encompass Health (NYSE:EHC) pays an annual dividend of $0.60 per share and currently has a dividend yield of 0.97%. The dividend payout ratio is 22.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EHC will have a dividend payout ratio of 18.58% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EHC.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health updated its FY 2022 earnings guidance on Wednesday, November, 2nd. The company provided EPS guidance of $2.71-$2.86 for the period, compared to the consensus EPS estimate of $2.86. The company issued revenue guidance of $4.32 billion-$4.35 billion, compared to the consensus revenue estimate of $4.36 billion.

What is Mark Tarr's approval rating as Encompass Health's CEO?

231 employees have rated Encompass Health Chief Executive Officer Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among the company's employees.

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Who are Encompass Health's major shareholders?

Encompass Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Copeland Capital Management LLC (0.99%), Reinhart Partners Inc. (0.79%), Wedge Capital Management L L P NC (0.55%), Bernzott Capital Advisors (0.39%), Natixis Advisors L.P. (0.18%) and Comerica Bank (0.18%). Insiders that own company stock include Andrew L Price, Donald L Correll, Elissa Joy Charbonneau, Greg D Carmichael, Kevin J O'connor, Mark J Tarr and Terrance Williams.
View institutional ownership trends
.

How do I buy shares of Encompass Health?

Shares of EHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $61.39.

How much money does Encompass Health make?

Encompass Health (NYSE:EHC) has a market capitalization of $6.13 billion and generates $5.12 billion in revenue each year. The company earns $412.20 million in net income (profit) each year or $2.72 on an earnings per share basis.

How many employees does Encompass Health have?

The company employs 43,400 workers across the globe.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The official website for the company is www.healthsouth.com. The company can be reached via phone at (205) 967-7116, via email at investorrelations@healthsouth.com, or via fax at 205-969-4719.

This page (NYSE:EHC) was last updated on 1/28/2023 by MarketBeat.com Staff